Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2008

01-01-2008 | Original Paper

The Benefit of the Supplementation of Perioperative Branched-Chain Amino Acids in Patients with Surgical Management for Hepatocellular Carcinoma: a Preliminary Study

Authors: Takehiro Okabayashi, Isao Nishimori, Takeki Sugimoto, Shinji Iwasaki, Naoaki Akisawa, Hiromichi Maeda, Satoshi Ito, Saburo Onishi, Yasuhiro Ogawa, Michiya Kobayashi, Kazuhiro Hanazaki

Published in: Digestive Diseases and Sciences | Issue 1/2008

Login to get access

Abstract

The aim of this work was to study the benefit of supplementation with a branched chain amino acids enriched nutrient mixture on the physical and mental condition following hepatic surgery in patients with hepatocellular carcinoma (HCC). A total of 41 patients with HCC who underwent hepatic surgery (36 hepatic resection and five radiofrequency ablation therapy) were enrolled in this comparative study. These patients were divided into two groups: 13 patients received perioperative supplementation of a branched chain amino acids enriched nutrient mixture (AEN group) and 28 patients did not (control group). Between these two groups, laboratory data, postoperative complications and the length of hospital stay were analyzed comparatively. Restoration of peripheral lymphocyte count and serum total cholesterol level at 3 months after the operation was significantly faster in the AEN group than in the control group (P < 0.05). The length of hospitalization in the AEN group was significantly shorter than in the control group (P < 0.05). This preliminary case control study suggested that the perioperative supplementation of a branched chain amino acids enriched nutrient mixture is of clinical benefit for nutritional support of patients surgically managed for HCC in chronic liver disease.
Literature
1.
go back to reference Hu QG, Zheng QC (2003) The influence of enteral nutrition in postoperative patients with poor liver function. World J Gastroenterol 9:843–846PubMed Hu QG, Zheng QC (2003) The influence of enteral nutrition in postoperative patients with poor liver function. World J Gastroenterol 9:843–846PubMed
2.
go back to reference Poon RT, Fan ST, Yu WC, Lam BK, Chan FY, Wong J (2001) A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surg 136:693–699PubMedCrossRef Poon RT, Fan ST, Yu WC, Lam BK, Chan FY, Wong J (2001) A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surg 136:693–699PubMedCrossRef
3.
go back to reference Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef
4.
go back to reference Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y et al (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134:984–992PubMedCrossRef Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y et al (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134:984–992PubMedCrossRef
5.
go back to reference Okabayashi T, Kobayashi M, Akimori T, Akisawa N, Iwasaki S, Onishi S et al (2005) Usefulness of laparoscopic radiofrequency ablation of hepatocellular carcinoma. Surg Technol Int 14:177–181PubMed Okabayashi T, Kobayashi M, Akimori T, Akisawa N, Iwasaki S, Onishi S et al (2005) Usefulness of laparoscopic radiofrequency ablation of hepatocellular carcinoma. Surg Technol Int 14:177–181PubMed
6.
go back to reference Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J (1994) Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 331:1547–1552PubMedCrossRef Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J (1994) Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 331:1547–1552PubMedCrossRef
7.
go back to reference Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G et al (2001) Nutrition and survival in patients with liver cirrhosis. Nutrition 17:445–450PubMedCrossRef Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G et al (2001) Nutrition and survival in patients with liver cirrhosis. Nutrition 17:445–450PubMedCrossRef
8.
go back to reference Tajika M, Kato M, Mohri H, Miwa Y, Kato T, Ohnishi H et al (2002) Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 18:229–234PubMedCrossRef Tajika M, Kato M, Mohri H, Miwa Y, Kato T, Ohnishi H et al (2002) Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 18:229–234PubMedCrossRef
9.
go back to reference Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M (2004) Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 313:405–409PubMedCrossRef Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M (2004) Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 313:405–409PubMedCrossRef
10.
go back to reference Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Italian BCAA Study Group et al (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124:1792–1801PubMedCrossRef Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Italian BCAA Study Group et al (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124:1792–1801PubMedCrossRef
11.
go back to reference QualityMetric (1997) SF-36.org. A community for measuring health outcomes using SF tools. http://www.sf-36.org QualityMetric (1997) SF-36.org. A community for measuring health outcomes using SF tools. http://​www.​sf-36.​org
12.
go back to reference Ikegami N, Drummond M, Fukuhara S, Nishimura S, Torrance GW, Scubert F (2002) Why has the use of health economic evaluation in Japan lagged behind that in other development countries? Pharmacoeconomics 20:1–7PubMedCrossRef Ikegami N, Drummond M, Fukuhara S, Nishimura S, Torrance GW, Scubert F (2002) Why has the use of health economic evaluation in Japan lagged behind that in other development countries? Pharmacoeconomics 20:1–7PubMedCrossRef
13.
go back to reference Ikeda Y, Kanematsu T, Matsumata T, Shimada M, Yamagata M, Sugimachi K (1993) Liver resection and intractable postoperative ascites. Hepatogastroenterology 40:14–16PubMed Ikeda Y, Kanematsu T, Matsumata T, Shimada M, Yamagata M, Sugimachi K (1993) Liver resection and intractable postoperative ascites. Hepatogastroenterology 40:14–16PubMed
14.
go back to reference Pol B, Campan P, Hardwigsen J, Botti G, Pons J, Le Treut YP (1999) Morbidity of major hepatic resections: a 100-case prospective study. Eur J Surg 165:446–453PubMedCrossRef Pol B, Campan P, Hardwigsen J, Botti G, Pons J, Le Treut YP (1999) Morbidity of major hepatic resections: a 100-case prospective study. Eur J Surg 165:446–453PubMedCrossRef
15.
go back to reference Laurent A, Cherqui D, Lesurtel M, Brunetti F, Tayar C, Fagniez PL (2003) Laparoscopic liver resection for subcapsular hepatocellular carcinoma complicating chronic liver disease. Arch Surg 138:763–769PubMedCrossRef Laurent A, Cherqui D, Lesurtel M, Brunetti F, Tayar C, Fagniez PL (2003) Laparoscopic liver resection for subcapsular hepatocellular carcinoma complicating chronic liver disease. Arch Surg 138:763–769PubMedCrossRef
16.
go back to reference Yamashita Y, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Shimada M, Sugimachi K (2001) Bile leakage after hepatic resection. Ann Surg 233:45–50PubMedCrossRef Yamashita Y, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Shimada M, Sugimachi K (2001) Bile leakage after hepatic resection. Ann Surg 233:45–50PubMedCrossRef
17.
go back to reference Tanaka S, Hirohashi K, Tanaka H, Shuto T, Lee SH, Kubo S, Takemura S, Yamamoto T, Uenishi T, Kinoshita H (2002) Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J Am Coll Surg 195:484–489PubMedCrossRef Tanaka S, Hirohashi K, Tanaka H, Shuto T, Lee SH, Kubo S, Takemura S, Yamamoto T, Uenishi T, Kinoshita H (2002) Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J Am Coll Surg 195:484–489PubMedCrossRef
18.
go back to reference Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW (2005) Risk factors associated with bile leakage after hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 52:1168–1171PubMed Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW (2005) Risk factors associated with bile leakage after hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 52:1168–1171PubMed
19.
go back to reference Poon RT, Yu WC, Fan ST, Wong J (2004) Long-term oral branched chain amino acids in patients undergoing chemoembolozation for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther 19:779–788PubMedCrossRef Poon RT, Yu WC, Fan ST, Wong J (2004) Long-term oral branched chain amino acids in patients undergoing chemoembolozation for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther 19:779–788PubMedCrossRef
20.
go back to reference Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H (2005) Effects of oral branched-chain amino acids granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3:705–713PubMedCrossRef Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H (2005) Effects of oral branched-chain amino acids granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3:705–713PubMedCrossRef
21.
go back to reference Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H, Ohashi Y (2006) Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acids granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 35:204–214PubMed Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H, Ohashi Y (2006) Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acids granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 35:204–214PubMed
22.
go back to reference Bianchi G, Marzocchi R, Agostini F, Marchesini G (2005) Update on branched-chain amino acid supplementation in liver diseases. Curr Opin Gastroenterol 21:197–200PubMedCrossRef Bianchi G, Marzocchi R, Agostini F, Marchesini G (2005) Update on branched-chain amino acid supplementation in liver diseases. Curr Opin Gastroenterol 21:197–200PubMedCrossRef
23.
go back to reference Pichard C, Kyle UG, Morabia A, Perrier A, Vermeulen B, Unger P (2004) Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr 79:613–618PubMed Pichard C, Kyle UG, Morabia A, Perrier A, Vermeulen B, Unger P (2004) Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr 79:613–618PubMed
24.
go back to reference Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D (1999) Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 45:295–300PubMedCrossRef Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D (1999) Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 45:295–300PubMedCrossRef
Metadata
Title
The Benefit of the Supplementation of Perioperative Branched-Chain Amino Acids in Patients with Surgical Management for Hepatocellular Carcinoma: a Preliminary Study
Authors
Takehiro Okabayashi
Isao Nishimori
Takeki Sugimoto
Shinji Iwasaki
Naoaki Akisawa
Hiromichi Maeda
Satoshi Ito
Saburo Onishi
Yasuhiro Ogawa
Michiya Kobayashi
Kazuhiro Hanazaki
Publication date
01-01-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9844-y

Other articles of this Issue 1/2008

Digestive Diseases and Sciences 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.